Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Chemical Listing >> F >> (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one

(R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
[CAS# 149524-42-5]

List of Suppliers
Capot Chemical Co., Ltd. China Inquire  
+86 (571) 8558-6718
+86 13336195806
capotchem@gmail.com
sales@capotchem.com
QQ chat
Chemical manufacturer
chemBlink standard supplier since 2006
LONGRE Pharmaceuticals Co., Ltd. China Inquire  
+86 (512) 6959-2836
+86 13306132836
sales@longrepharm.com
yuguojun1013@163.com
Chemical manufacturer since 2011
chemBlink standard supplier since 2011
Tianjin Chempharmatech Co., Ltd. China Inquire  
+86 (22) 6621-1079
wuzhanyuan@chempharmatech.com
Chemical manufacturer since 2012
chemBlink standard supplier since 2016
Shanghai Fuxin Pharmaceutical Co., Ltd. China Inquire  
+86 (21) 3130-0828
+86 18645121291
contact@fuxinpharm.com
Chemical manufacturer since 2016
chemBlink standard supplier since 2018
AK Scientific, Inc USA Inquire  
+1 (510) 429-8835
sales@aksci.com
Chemical manufacturer
Complete supplier list of (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
Identification
Name (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
Molecular Structure CAS # 149524-42-5, (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
Molecular Formula C10H10FNO3
Molecular Weight 211.19
CAS Registry Number 149524-42-5
EC Number 635-089-0
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Skin irritationSkin Irrit.2H315
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2H319
SDS Available
Market Analysis Reports
List of Reports Available for (R)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one
Related Products
4-Fluorophenylhydrazine hydrochloride  4-(4-Fluorophenyl)-7-hydroxy-2H-1-benzopyran-2-one  3-(3-Fluorophenyl)-1-[2-hydroxy-4,6-bis(phenylmethoxy)phenyl]-2-propen-1-one  4-(4-Fluorophenyl)-2-hydroxy-6-isopropylpyrimidine-5-carbonitrile  (betaR,deltaR)-2-(4-Fluorophenyl)-delta-hydroxy-beta-methoxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid  4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine  (deltaR)-2-(4-Fluorophenyl)-delta-hydroxy-5-(1-methylethyl)-beta-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid  (3S,4R)-4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine  4-(4-Fluorophenyl)-3-hydroxymethyl-1-methyl-piperidine  (S)-3-(3-Fluorophenyl)-5-(hydroxymethyl)oxazolidin-2-one  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid phenylmethyl ester  (3S,4R)-4-(4-Fluorophenyl)-3-(hydroxymethyl)-1-piperidinecarboxylic acid tert-butyl ester  (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid calcium salt  (3R,5S,6E)-7-[4-(4-Fluorophenyl)-2-[[(2-hydroxy-2-methylpropyl)sulfonyl]methylamino]-6-(1-methylethyl)-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid sodium salt (1:1)  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-(phenylmethyl)-2-oxazolidinone  (4S)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (4R)-3-[(5R)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone  (5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone  3-[5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyloxazolidin-2-one  (4S)-3-[(5S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one